IPO Timeline
Broker Results (T-2)
2022-09-29
Some brokers release in afternoon
Grey Market (T-1)
2022-09-30
Afternoon
HKEX Allotment (T-1)
2022-09-30
Evening
Registrar Allotment (T-1)
2022-09-30
Evening
Listing Day (T)
2022-10-03
First day of trading
Company Overview
| Stock Name | 百德医疗 |
|---|---|
| Stock Code | 06678 |
| Company Full Name | 百德医疗 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事微波消融及其他醫療器械的研發、制造及銷售。 |
| Listing Date | 2022-10-03 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省廣州市越秀區中山三路33號中華國際中心B座17樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://baidesz.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | To be extracted |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | To be extracted |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 2,000 | HK$ 2,800 |
| 2 lots | 4,000 | HK$ 5,600 |
| 3 lots | 6,000 | HK$ 8,400 |
| 4 lots | 8,000 | HK$ 11,200 |
| 5 lots | 10,000 | HK$ 14,000 |
| 10 lots | 20,000 | HK$ 28,000 |
| 15 lots | 30,000 | HK$ 42,000 |
| 20 lots | 40,000 | HK$ 56,000 |
| 25 lots | 50,000 | HK$ 70,000 |
| 30 lots | 60,000 | HK$ 84,000 |
| 35 lots | 70,000 | HK$ 98,000 |
| 40 lots | 80,000 | HK$ 112,000 |
| 45 lots | 90,000 | HK$ 126,000 |
| 50 lots | 100,000 | HK$ 140,000 |
| 100 lots | 200,000 | HK$ 280,000 |
| 150 lots | 300,000 | HK$ 420,000 |
| 200 lots | 400,000 | HK$ 560,000 |
| 250 lots | 500,000 | HK$ 700,000 |
| 300 lots | 600,000 | HK$ 840,000 |
| 350 lots | 700,000 | HK$ 980,000 |
| 400 lots | 800,000 | HK$ 1,120,000 |
| 500 lots | 1,000,000 | HK$ 1,400,000 |
| 1,500 lots | 3,000,000 | HK$ 4,200,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | Loading... |
|---|---|
| First Day Open | HK$ -- |
Use of Proceeds
| Use of Proceeds | 1、106.3百萬港元（相當于人民幣93.8百萬元）（即所得款項凈額41.0%）將用作擴大及深化我們的產品組合、升級我們的醫療許可證及擴充研發團隊； 2、98.5百萬港元（相當于人民幣87.0百萬元）（即所得款項凈額38.0%）將用作選擇性尋求能夠補充我們的現有產品組合、銷售及分銷網絡、技術并為我們的業務增長創造協同效應的策略收購、投資或業務協同合作機會； 3、20.7百萬港元（相當于人民幣18.3百萬元）（即所得款項凈額8.0%）將用作透過設立海外辦事處擴大我們在國外及新興市場的地位； 4、7.8百萬港元（相當于人民幣6.9百萬元）（即所得款項凈額3.0%）將用于購買自動化機械及設備以提高我們的生產線的自動化水平； 5、26.0百萬港元（相當于人民幣22.9百萬元）（即所得款項凈額10.0%）將用作額外營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
中银国际亚洲有限公司 CE AET863
中泰国际融资有限公司 CE BBY334
Overall Coordinators (4)
中银国际亚洲有限公司 CE AET863
中泰国际证券有限公司 CE BAA855
中国银河国际证券（香港）有限公司 CE AXM459
信达国际融资有限公司 CE AEE541
Joint Bookrunners (10)
中银国际亚洲有限公司 CE AET863
中泰国际证券有限公司 CE BAA855
中国银河国际证券（香港）有限公司 CE AXM459
信达国际融资有限公司 CE AEE541
华泰金融控股（香港）有限公司 CE AOK809
艾德证券期货有限公司 CE BHT550
中国光大证券（香港）有限公司 CE AAW536
Guosen Securities (HK) Capital Company Limited CE AUX600
兴证国际融资有限公司 CE BAK956
华盛资本证券有限公司 CE AUL711
Joint Lead Managers (11)
中银国际亚洲有限公司 CE AET863
中泰国际证券有限公司 CE BAA855
中国银河国际证券（香港）有限公司 CE AXM459
信达国际融资有限公司 CE AEE541
华泰金融控股（香港）有限公司 CE AOK809
艾德证券期货有限公司 CE BHT550
中国光大证券（香港）有限公司 CE AAW536
Guosen Securities (HK) Capital Company Limited CE AUX600
兴证国际融资有限公司 CE BAK956
华盛资本证券有限公司 CE AUL711
ZMF Asset Management Limited CE AWF641
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 吳海梅 |
|---|---|
| Company Secretary | 吳冠誠 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 吳海梅(50.65%);中國銀行股份有限公司(7.03%) |
|---|
Subscription Tiers
IPO Timeline
